Indications and Purposes
| 1 Indications And Usage Mycapssa Is Indicated For Long-Term Maintenance Treatment In Acromegaly Patients Who Have Responded To And Tolerated Treatment With Octreotide Or Lanreotide. Mycapssa Is A Somatostatin Analog Indicated For Long-Term Maintenance Treatment In Acromegaly Patients Who Have Responded To And Tolerated Treatment With Octreotide Or Lanreotide ( 1 ). |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Octreotide |
|
ZINC150338696 |